For HIV / AIDS, Tuberculosis, Malaria
Portable and cost-efficient solutions for improved patient care of adults and children

Resource-poor and developing countries are suffering most from the three global diseases HIV/AIDS, Tuberculosis and Malaria - this includes a disastrous impact on humanitarian, social, and economic aspects.

Life expectancy in some countries decreased to less than 35 years. After 30 years of AIDS, despite the increasingly available funds, the vast majority of indivuals urgently requiring controlled antiretroviral treatment still is not being covered by the necessary health services. As by now antiretroviral drugs and suitable Malaria medicines have become more and more available, the main bottleneck is the lack in dedicated affordable, robust, and easy-to-use diagnostic equipment and reliable protocols.

A high percentage of HIV/AIDS patients suffers from coinfections with tuberculosis, Malaria parasites, and other infectious diseases. In addition to this, treatment of acute Malaria cases with erythrocyte support represents a serious risk to transmit the HI virus. In order to serve the patients in the most effective way, the management of the three major diseases has to be consequently combined. This requires dedicated and suitable diagnostic tools which are specifically adapted to the situation in low- and mid-income countries and in resource-poor settings which previously have not been covered due to complexity and high cost of conventional equipment.

The Partec Essential Healthcare division develops, manufactures and distributes dedicated diagnostic solutions in the global fight against HIV/AIDS, TB and Malaria. The CyFlow® technique has provided the world with the first mobile/portable flow cytometry instrument, introduced in order to serve the rapidly growing demand of low- and mid-income countries for robust, easy-to-operate, accurate and affordable instrumentation for HIV monitoring and AIDS patient follow-up. In the last few years, more than 1500 CyFlow units have been successfully implemented in 100 countries worldwide for CD4 and CD4% counting within national treatment programmes and NGO projects. Alone from 2008 to 2010, a total quantity of 8 million Partec patient tests were used. Since end of 2006 the CyScope®, an ultracompact and battery-operated fluorescence microscope, is available for easy-to-perform and affordable high-sensitivity detection of TB and Malaria.